Cognision and SOMNOmedics partner to provide sleep-biomarker tools in trials

Cognision has entered a strategic partnership with SOMNOmedics AG to advance the use of sleep biomarkers in pharmaceutical clinical trials. According to the company, Cognision will supply SOMNOmedics’ next-generation polysomnography (PSG) systems, tailored for use in regulated research environments.…